SITOY GROUP (01023): Li Baoyu appointed as Chairman of the Compensation Committee.
Huarui Group Holdings (01023) announced that effective from the conclusion of the shareholders' annual meeting, Dr. Liu Jiancheng retired from his position as non-executive...
SITOY GROUP (01023) announced that, effective immediately after the conclusion of the shareholders' annual general meeting, Dr. Liu Jiancheng will retire as a non-executive director and will no longer be a member of the company's Environment, Social and Governance Committee. Mr. Long Hongzhao will retire as an independent non-executive director and will no longer serve as the chairman of the company's Remuneration Committee, as well as a member of the company's Audit Committee and Nomination Committee. Ms. Li Baoyu has been appointed as the chairman of the company's Remuneration Committee.
Related Articles
CK LIFE SCIENCES(00775): Positive results achieved in the mid-term analysis of the Phase IIb study of Halneuron in treating chemotherapy-induced neuropathic pain.
Bitcoin winter is coming? Whale Strategy (MSTR.US) pauses buying spree, hoarding $2.2 billion in cash to prepare for winter.
Shanghai Fosun Pharmaceutical (02196) responds to the acquisition of LvGu Pharmaceutical: The confirmatory clinical research on mannitol sodium capsules has been recognized by the Drug Evaluation Center, with a total of 580 cases enrolled.
CK LIFE SCIENCES(00775): Positive results achieved in the mid-term analysis of the Phase IIb study of Halneuron in treating chemotherapy-induced neuropathic pain.
Bitcoin winter is coming? Whale Strategy (MSTR.US) pauses buying spree, hoarding $2.2 billion in cash to prepare for winter.
Shanghai Fosun Pharmaceutical (02196) responds to the acquisition of LvGu Pharmaceutical: The confirmatory clinical research on mannitol sodium capsules has been recognized by the Drug Evaluation Center, with a total of 580 cases enrolled.
